Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMBLE-AS: Effects on Ambulatory Arterial Stiffness of Calcium Channel Blocker vs Diuretic in Combination With Angiotensin II Receptor Blocker in Hypertensive Patients
KCT0003595Phase 4Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of resomelagon in hypertension (HTN), sponsored by Daiichi Sankyo Co., Ltd.. Started Mar 2019; status: completed.
02
Drugs
resomelagon
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on KCT0003595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0003595.